Needham Reiterates Buy on HashiCorp, Maintains $39 Price Target
Needham analyst Alex Henderson reiterates HashiCorp (NASDAQ:HCP) with a Buy and maintains $39 price target.
United Airlines To Rally Around 54%? Here Are 10 Other Analyst Forecasts For Friday
Piper Sandler raised the price target for Riskified Ltd. (NYSE: RSKD) from $6 to $8. Piper Sandler analyst Brent Bracelin upgraded the stock from Neutral to Overweight. Riskified shares rose 2.4% to $5.51 in pre-market trading.
Raymond James Maintains Outperform on Holley, Raises Price Target to $3.5
Raymond James analyst Joseph Altobello maintains Holley (NYSE:HLLY) with a Outperform and raises the price target from $3 to $3.5.
Needham Reiterates Buy on Stratasys, Maintains $15 Price Target
Needham analyst James Ricchiuti reiterates Stratasys (NASDAQ:SSYS) with a Buy and maintains $15 price target.
Needham Reiterates Buy on AgileThought, Maintains $7 Price Target
Needham analyst Mayank Tandon reiterates AgileThought (NASDAQ:AGIL) with a Buy and maintains $7 price target.
HC Wainwright & Co. Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $30
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and lowers the price target from $65 to $30.
HC Wainwright & Co. Reiterates Neutral on Akebia Therapeutics, Maintains $1.25 Price Target
HC Wainwright & Co. analyst Ed Arce reiterates Akebia Therapeutics (NASDAQ:AKBA) with a Neutral and maintains $1.25 price target.
Evercore ISI Group Upgrades Bionomics to Outperform, Announces $6 Price Target
Evercore ISI Group analyst Joshua Schimmer upgrades Bionomics (NASDAQ:BNOX) from In-Line to Outperform and announces $6 price target.
Jefferies Upgrades Roblox to Buy, Raises Price Target to $48
Jefferies analyst Andrew Uerkwitz upgrades Roblox (NYSE:RBLX) from Hold to Buy and raises the price target from $30 to $48.
Barclays Downgrades Southwest Airlines to Equal-Weight, Lowers Price Target to $38
Barclays analyst Brandon Oglenski downgrades Southwest Airlines (NYSE:LUV) from Overweight to Equal-Weight and lowers the price target from $42 to $38.